Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AEterna falls on stock offering; Rexahn rallies
Marketwatch
Friday, April 16, 2010 - 11:13am
tags:
Aeterna Zentaris, Rexahn
Repligen expects losses in 2010, 2011
Yahoo/AP
Friday, April 16, 2010 - 9:57am
tags:
Repligen, earnings
Pharma Debt Is Outstripping Growth In Cash
Pharmalot
Friday, April 16, 2010 - 9:56am
tags:
pharma industry, debt, credit rating
Everything You Thought You Knew About Cancer Is About to Change
BNET Pharma
Friday, April 16, 2010 - 9:55am
tags:
cancer, personalized medicine, biotech, Foundation Medicine
Boston Scientific Cleared to Resume Device Sales
Bloomberg
Friday, April 16, 2010 - 9:01am
tags:
defibrillators, Boston Scientific, FDA
Looking East, Big Pharma Cuts Prices
Businessweek
Friday, April 16, 2010 - 9:00am
tags:
Asia, drug pricing, Big Pharma
Impax says it is now marketing Lyrica as a seizure treatment, and is not co-promoting Pristiq
Yahoo/AP
Friday, April 16, 2010 - 8:14am
tags:
Impax, Lyrica, Pristiq, Pfizer
Cubist Pharmaceuticals' 1Q profit nearly triples
Yahoo/AP
Thursday, April 15, 2010 - 10:12pm
tags:
Cubist Pharmaceuticals, earnings
Merck & Co., Inc. (NYSE:MRK): First Quarter Earnings Preview 2010
iStockAnalyst
Thursday, April 15, 2010 - 3:57pm
tags:
Merck, earnings
Trimeris: Sales of Fuzeon drop 12%
Bizjournals.com
Thursday, April 15, 2010 - 3:40pm
tags:
Trimeris, Fuzeon
AEterna Zentaris stock rises after study reviewed
Yahoo/AP
Thursday, April 15, 2010 - 3:39pm
tags:
Aeterna Zentaris, perifosine
Moody's says big pharma credit ratings are at risk
Yahoo/AP
Thursday, April 15, 2010 - 3:38pm
tags:
credit rating, Big Pharma
REMICADE(R) Study Results Show Greater Steroid-Free Remission and Mucosal Healing Compared With Conventional Immunomodulator Azathioprine in Treatment of Crohn's Disease
PR Newswire
Thursday, April 15, 2010 - 10:12am
tags:
Remicade, Crohn's Disease, JNJ
Santarus tumbles on court patent ruling
Marketwatch
Thursday, April 15, 2010 - 10:06am
tags:
Santarus, patents, Zegerid
UK Sentences Former J&J Exec For Corruption
Pharmalot
Thursday, April 15, 2010 - 10:01am
tags:
fraud, UK, JNJ, DePuy
Roche to Ask FDA to Approve Targeted Breast Cancer Drug Early
Bloomberg
Thursday, April 15, 2010 - 9:59am
tags:
Roche, FDA, breast cancer
Positive MS data may thwart Icahn's plans for Genzyme
Fierce Biotech
Thursday, April 15, 2010 - 9:58am
tags:
MS, multiple sclerosis, Campath, Carl Icahn, Genzyme
Celgene deal means $130m for Agios
Boston.com
Thursday, April 15, 2010 - 9:53am
tags:
Celgene, Agios Pharmaceuticals
PowerPoint Fail: Pfizer Slideshow Depicts Neurontin as a Witch's Brew
BNET Pharma
Thursday, April 15, 2010 - 9:52am
tags:
Neurontin, Pfizer, off-label
Roche numbers boost European drugmakers
FT.com
Thursday, April 15, 2010 - 9:33am
tags:
Roche, Europe, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.